Jörn Schattenberg, MD

home / authors / j-rn-schattenberg-md

Jörn Schattenberg, MD, is a professor of medicine and director of the Metabolic Liver Research Program at the University Medical Center Mainz in Germany.

Articles

Jörn Schattenberg, MD | Credit: Novo Nordisk

Jörn Schattenberg, MD: Preventing MASH Cirrhosis Progression with Pegozafermin

Jörn Schattenberg, MD;Abigail Brooks, MA
December 6th 2024

Schattenberg reviews results from a posthoc analysis of the ENLIVEN study suggesting pegozafermin’s impact on preventing progression to cirrhosis.

Read More

Jörn Schattenberg, MD | Credit: Novo Nordisk

Jörn Schattenberg, MD: Pegozafermin and Preventing Progression to Cirrhosis in MASH

Jörn Schattenberg, MD;Abigail Brooks, MA
December 5th 2024

Schattenberg explains pegozafermin’s mechanism of action and describes the importance of preventing progression to cirrhotic MASH.

Read More

Latest Updated Articles

Gursimran Kochhar, MD | Credit: Allegheny Health Network
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
HCPLive Cardiology Month in Review: April 2024
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies
Published: November 16th 2024 | Updated: December 22nd 2024
Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Published: November 15th 2024 | Updated: December 22nd 2024
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Scott Bartley, MD I Credit: LinkedIn
Published: December 16th 2024 | Updated: December 22nd 2024
Brilaroxazine Shows Long-Term Efficacy in Schizophrenia in Phase 3 RECOVER
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
Published: December 16th 2024 | Updated: December 22nd 2024
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
© 2024 MJH Life Sciences

All rights reserved.